Anavex Life Sciences Corp (AVXL)

[Investor2014]

"tax rebate" is a misleading description. it is a

43.5% “cash back” benefit

against the R&D expenses the company's Australian entity incurs.

R&D Tax Incentive

Maybe we can move on to something else once you have read this.